info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

US Generic Injectables Market Research Report, by Product Type (Monoclonal antibodies, Cytokines, Insulin, Vaccines), Container (Vials, Ampoules, Premix, Prefilled syringes), Application (Oncology, Anaesthesia, Anti-infectives, Cardiovascular), Distribution Channel (Hospital pharmacy, Retail pharmacy, Drug stores, Online stores) – Forecast Till 2030


ID: MRFR/HC/11480-CR | 100 Pages | Author: Garvit Vyas| December 2023

The generic injectables market is experiencing a significant surge in demand due to several factors, including the increasing prevalence of chronic diseases, rising healthcare costs, and the expiration of patents on branded injectable drugs. Generic injectables are identical or bioequivalent versions of brand-name injectable medications, offering the same quality, safety, and efficacy at a lower cost. With the growing burden of chronic conditions such as diabetes, cardiovascular diseases, and cancer, there is a rising demand for injectable drugs to manage symptoms, control disease progression, and improve patient outcomes. Generic injectables provide a cost-effective alternative to branded medications, making them accessible to a broader patient population and reducing healthcare expenditures.


Moreover, the expiration of patents on branded injectable drugs has opened up opportunities for generic pharmaceutical companies to enter the market and introduce affordable alternatives. As patents expire, generic manufacturers can develop and market their versions of injectable drugs, leading to increased competition and price reductions. This competition drives down the cost of generic injectables, making them more attractive to healthcare providers, payers, and patients alike. Additionally, the availability of multiple generic options for a given medication promotes price transparency and fosters market competition, further driving down prices and increasing accessibility.


Furthermore, the growing preference for outpatient and ambulatory care settings is fueling demand for generic injectables that can be administered outside of traditional hospital settings. As healthcare delivery models evolve to prioritize convenience, cost-effectiveness, and patient-centered care, there is an increasing shift towards outpatient procedures, including injectable treatments. Generic injectables play a crucial role in outpatient settings, where they are used to treat a wide range of conditions, from acute infections and pain management to chronic diseases and oncology treatments. The availability of affordable generic injectables enables healthcare providers to deliver high-quality care to patients in non-hospital settings, reducing healthcare costs and improving patient satisfaction.


Additionally, the global COVID-19 pandemic has underscored the importance of generic injectables in responding to public health emergencies and ensuring access to essential medications. During the pandemic, there was a surge in demand for injectable drugs used in the treatment of COVID-19 patients, such as antivirals, corticosteroids, and antibiotics. Generic injectables played a critical role in meeting this increased demand, providing healthcare providers with cost-effective options to treat patients and manage symptoms. Additionally, generic injectables used in the treatment of other medical conditions, such as respiratory diseases, diabetes, and cardiovascular disorders, remained essential for ongoing patient care amidst the pandemic, further driving demand for these medications.


Furthermore, the growing emphasis on biosimilars and complex generics is expanding the scope of the generic injectables market, creating opportunities for innovation and differentiation. Biosimilars are highly similar versions of biologic drugs, including injectables, that have been shown to be comparable in terms of safety, efficacy, and quality to their reference products. Similarly, complex generics are generic versions of injectable drugs that may have more complex formulations or delivery systems than traditional small-molecule drugs. As regulatory pathways for biosimilars and complex generics become more established, generic manufacturers are investing in the development and commercialization of these products, expanding the range of options available to healthcare providers and patients.

Report Attribute/Metric Details
Market Size 2022 USD 79.5 billion
Market Size 2023 USD 83.6 billion
Market Size 2032 USD 124.59 Billion
Compound Annual Growth Rate (CAGR)  5.1% (2023-2030)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018 - 2021
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Material, Type, Design, End-User, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The U.S, Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled SCHOTT AG, BD, Gerresheimer AG, West Pharmaceutical Services Inc, AptarGroup Inc., Helvoet Rubber & Plastic Technologies B.V., Terumo Corporation, Nipro PharmaPackaging International Company.
Key Market Opportunities spending on health will get a huge boost
Key Market Dynamics Rising Demand for self-injection and related devices Rising numbers, incidence and prevalence of various chronic diseases


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.